倍轻松扣非连亏四年 2021年上市即巅峰国投证券保荐

Core Viewpoint - The company reported a significant decline in both revenue and net profit for the fiscal year 2025, indicating ongoing financial challenges and a downward trend in performance compared to the previous year [1][3]. Financial Performance Summary - The total operating revenue for 2025 was 771.09 million yuan, a decrease of 28.94% compared to the previous year [1][3]. - The operating profit was -95.26 million yuan, down 964.23% from a profit of 11.02 million yuan in the prior year [3]. - The total profit was -98.50 million yuan, a decline of 932.85% from a profit of 11.83 million yuan in the previous year [3]. - The net profit attributable to the parent company's shareholders was -89.30 million yuan, a decrease of 970.90% from a profit of 10.25 million yuan in the previous year [1][3]. - The net profit attributable to the parent company after deducting non-recurring gains and losses was -87.97 million yuan, compared to -3.27 million yuan in the previous year [1][3]. Historical Financial Data - The company's net profit excluding non-recurring items for the years 2022, 2023, and 2024 were -130 million yuan, -55.99 million yuan, and -3.27 million yuan respectively [3]. - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on July 15, 2021, with an initial public offering of 15.41 million shares at a price of 27.40 yuan per share [3][4]. Fundraising and Use of Proceeds - The total amount raised during the IPO was 422 million yuan, with a net amount of 359 million yuan after deducting issuance costs, which was 138 million yuan less than the originally planned net fundraising amount [4]. - The funds were intended for projects including marketing network construction, R&D center upgrades, information technology upgrades, and working capital supplementation [4].